MDL Mass Tort & Class Action Monitor

Developed to serve primarily as a litigation scouting report for plaintiff and defense counsel, insurers and legal service providers, HarrisMartin’s MDL Mass Tort & Class Action Monitor covers significant new filings and decisions in the JPML, MDL and related mass tort arenas. The quick delivery of breaking news and additional features will keep you within close range of every development occurring in the high-stakes environment of mass torts litigation — where minutes can make a difference. The MDL Mass Tort & Class Action Monitor is an online-only offering that includes frequent email updates and is available at no charge to annual and event sponsors of HarrisMartin’s CLE Conferences.



Issue #31, September 2019

Apotex Corp. Issues ‘Precautionary’ Recall of Ranitidine Drugs

Apotex Corp. has announced that it is voluntarily recalling all of its ranitidine drugs in the United States due to reports that some brand name and generic ranitidine medicines have been contaminated by a probable human carcinogen known as N-Nitrosodimethylamine (NDMA).

Opioid MDL Judge Denies Defendants’ Request to Disqualify Himself

The Ohio federal judge overseeing the federal opioid multidistrict litigation has refused to disqualify himself, rejecting defendants’ arguments that his active participation in encouraging settlement talks is evidence that he is biased against them.

Wash. Man Sues Distributors of Vaping Pen After Developing Lipoid Pneumonia

A police officer has sued six distributors of a Chinese-made vaping pen in Washington state court, alleging his use of the product caused him to develop lipoid pneumonia.

Abilify MDL Judge Dismisses 149 Plaintiffs for Non-Compliance with Settlement Orders

A Florida federal judge has dismissed the claims of 149 Abilify plaintiffs with prejudice on the basis that they failed to comply with orders regarding a global settlement of all cases pending on the federal multidistrict litigation docket.

Sandoz Recalls Ranitidine Drugs, Citing NDMA Carcinogen Contamination

Sandoz Inc. has announced that it is voluntarily recalling all of its ranitidine drugs in the United States due to contamination by a probable human carcinogen known as N-Nitrosodimethylamine (NDMA), according to a MedWatch Safety Alert.

Fla. Woman Says Contaminated Zantac Caused Breast Cancer

A Florida woman has sued Sanofi-Aventis in federal court, alleging her long-term ingestion of the heartburn drug Zantac (ranitidine) caused her breast cancer because it was contaminated with a probable human carcinogen.

Fla. Man Says Contaminated Zantac Caused Rare Cancer

A Florida man has sued the maker of Zantac in Florida state court, alleging it concealed the fact that its acid reflux drug Zantac (ranitidine) contained “incredibly high levels” of a probable human carcinogen.

OxyCotin Maker Purdue Pharma Petitions for Chapter 11 Bankruptcy

Purdue Pharma L.P., maker of the addictive painkiller OxyCotin, has filed a voluntary petition for Chapter 11 bankruptcy in New York federal court following its agreement to settle thousands of lawsuits accusing it of perpetuating the opioid epidemic.

N.Y. Woman Says JUUL’s Marketing Efforts Caused ‘Debilitating’ Nicotine Addiction

An 18-year-old woman has sued the makers of JUUL e-cigarettes in New York federal court, alleging she developed a severe and debilitating nicotine addiction due to defendants’ aggressive advertising tactics aimed at a youth-oriented market.

FDA Issues Warning Letter Accusing JUUL of Marketing Products to Students as ‘Safe’

The Food and Drug Administration has issued a warning letter to JUUL Labs Inc., accusing it of marketing unauthorized modified risk tobacco products to consumers, including youths in schools, touting the products as “much safer than cigarettes.”

Past Issues:


The HarrisMartin VerdicTrack lets you track verdicts by product, state, defendant, or expert.